ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preclinical DMPK Studies Market Research Report 2026
Published Date: 2026-04-13
|
Report Code: QYRE-Auto-0K17556
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Preclinical DMPK Studies Market Research Report 2024
BUY CHAPTERS

Global Preclinical DMPK Studies Market Research Report 2026

Code: QYRE-Auto-0K17556
Report
2026-04-13
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River
LabCorp
Eurofins Scientific
PPD
Inotiv, Inc.
ChemPartner
Evotec AG
Medicilon
Crown Bioscience
Jubilant Biosys
Creative-Biolabs
Allucent
Sai Life Sciences
Sygnature Discovery
Q2 Solutions
Invitrocue
Frontage
Bioduro-Sundia
WuXi AppTec
Pharmaron
Joinn Laboratories
Tigermed

Preclinical DMPK Studies Market

The global Preclinical DMPK Studies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is used to assess the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate. This information is essential for understanding how a drug will behave in the body and for designing safe and effective clinical trials.
DMPK studies can be performed in vitro or in vivo. In vitro DMPK studies are typically used to screen a large number of compounds for their ADME properties and to identify promising candidates for further development. In vivo DMPK studies are typically performed later in drug development, after a compound has been shown to have promising ADME properties in vitro.
The North American market for Preclinical DMPK Studies is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Preclinical DMPK Studies is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Preclinical DMPK Studies in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Preclinical DMPK Studies include Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Preclinical DMPK Studies market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Preclinical DMPK Studies. The Preclinical DMPK Studies market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Preclinical DMPK Studies market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Preclinical DMPK Studies manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Preclinical DMPK Studies Market Report

Report Metric Details
Report Name Preclinical DMPK Studies Market
Segment by Type
  • In Vitro
  • In Vivo
Segment by Application
  • Pharmaceutical Companies
  • Medical Device Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, Creative Biolabs, Allucent, Sai Life Sciences, Sygnature Discovery, Q2 Solutions, Invitrocue, Frontage, BioDuro-Sundia, Wuxi AppTec, Pharmaron, JOINN Laboratories, Tigermed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Preclinical DMPK Studies companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Preclinical DMPK Studies Market report?

Ans: The main players in the Preclinical DMPK Studies Market are Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, Creative Biolabs, Allucent, Sai Life Sciences, Sygnature Discovery, Q2 Solutions, Invitrocue, Frontage, BioDuro-Sundia, Wuxi AppTec, Pharmaron, JOINN Laboratories, Tigermed

What are the Application segmentation covered in the Preclinical DMPK Studies Market report?

Ans: The Applications covered in the Preclinical DMPK Studies Market report are Pharmaceutical Companies, Medical Device Companies, Others

What are the Type segmentation covered in the Preclinical DMPK Studies Market report?

Ans: The Types covered in the Preclinical DMPK Studies Market report are In Vitro, In Vivo

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical DMPK Studies Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vitro
1.2.3 In Vivo
1.3 Market by Application
1.3.1 Global Preclinical DMPK Studies Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical DMPK Studies Market Perspective (2021–2032)
2.2 Global Preclinical DMPK Studies Growth Trends by Region
2.2.1 Global Preclinical DMPK Studies Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Preclinical DMPK Studies Historic Market Size by Region (2021–2026)
2.2.3 Preclinical DMPK Studies Forecasted Market Size by Region (2027–2032)
2.3 Preclinical DMPK Studies Market Dynamics
2.3.1 Preclinical DMPK Studies Industry Trends
2.3.2 Preclinical DMPK Studies Market Drivers
2.3.3 Preclinical DMPK Studies Market Challenges
2.3.4 Preclinical DMPK Studies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical DMPK Studies Players by Revenue
3.1.1 Global Top Preclinical DMPK Studies Players by Revenue (2021–2026)
3.1.2 Global Preclinical DMPK Studies Revenue Market Share by Players (2021–2026)
3.2 Global Top Preclinical DMPK Studies Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Preclinical DMPK Studies Revenue
3.4 Global Preclinical DMPK Studies Market Concentration Ratio
3.4.1 Global Preclinical DMPK Studies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical DMPK Studies Revenue in 2025
3.5 Global Key Players of Preclinical DMPK Studies Head Offices and Areas Served
3.6 Global Key Players of Preclinical DMPK Studies, Products and Applications
3.7 Global Key Players of Preclinical DMPK Studies, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Preclinical DMPK Studies Breakdown Data by Type
4.1 Global Preclinical DMPK Studies Historic Market Size by Type (2021–2026)
4.2 Global Preclinical DMPK Studies Forecasted Market Size by Type (2027–2032)
5 Preclinical DMPK Studies Breakdown Data by Application
5.1 Global Preclinical DMPK Studies Historic Market Size by Application (2021–2026)
5.2 Global Preclinical DMPK Studies Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Preclinical DMPK Studies Market Size (2021–2032)
6.2 North America Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Preclinical DMPK Studies Market Size by Country (2021–2026)
6.4 North America Preclinical DMPK Studies Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical DMPK Studies Market Size (2021–2032)
7.2 Europe Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Preclinical DMPK Studies Market Size by Country (2021–2026)
7.4 Europe Preclinical DMPK Studies Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Preclinical DMPK Studies Market Size (2021–2032)
8.2 Asia-Pacific Preclinical DMPK Studies Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Preclinical DMPK Studies Market Size by Region (2021–2026)
8.4 Asia-Pacific Preclinical DMPK Studies Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Preclinical DMPK Studies Market Size (2021–2032)
9.2 Latin America Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Preclinical DMPK Studies Market Size by Country (2021–2026)
9.4 Latin America Preclinical DMPK Studies Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical DMPK Studies Market Size (2021–2032)
10.2 Middle East & Africa Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Preclinical DMPK Studies Market Size by Country (2021–2026)
10.4 Middle East & Africa Preclinical DMPK Studies Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Preclinical DMPK Studies Introduction
11.1.4 Charles River Revenue in Preclinical DMPK Studies Business (2021–2026)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Preclinical DMPK Studies Introduction
11.2.4 Labcorp Revenue in Preclinical DMPK Studies Business (2021–2026)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Preclinical DMPK Studies Introduction
11.3.4 Eurofins Scientific Revenue in Preclinical DMPK Studies Business (2021–2026)
11.3.5 Eurofins Scientific Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Preclinical DMPK Studies Introduction
11.4.4 PPD Revenue in Preclinical DMPK Studies Business (2021–2026)
11.4.5 PPD Recent Development
11.5 Inotiv
11.5.1 Inotiv Company Details
11.5.2 Inotiv Business Overview
11.5.3 Inotiv Preclinical DMPK Studies Introduction
11.5.4 Inotiv Revenue in Preclinical DMPK Studies Business (2021–2026)
11.5.5 Inotiv Recent Development
11.6 ChemPartner
11.6.1 ChemPartner Company Details
11.6.2 ChemPartner Business Overview
11.6.3 ChemPartner Preclinical DMPK Studies Introduction
11.6.4 ChemPartner Revenue in Preclinical DMPK Studies Business (2021–2026)
11.6.5 ChemPartner Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Preclinical DMPK Studies Introduction
11.7.4 Evotec Revenue in Preclinical DMPK Studies Business (2021–2026)
11.7.5 Evotec Recent Development
11.8 Medicilon
11.8.1 Medicilon Company Details
11.8.2 Medicilon Business Overview
11.8.3 Medicilon Preclinical DMPK Studies Introduction
11.8.4 Medicilon Revenue in Preclinical DMPK Studies Business (2021–2026)
11.8.5 Medicilon Recent Development
11.9 Crown Bioscience
11.9.1 Crown Bioscience Company Details
11.9.2 Crown Bioscience Business Overview
11.9.3 Crown Bioscience Preclinical DMPK Studies Introduction
11.9.4 Crown Bioscience Revenue in Preclinical DMPK Studies Business (2021–2026)
11.9.5 Crown Bioscience Recent Development
11.10 Jubilant Biosys
11.10.1 Jubilant Biosys Company Details
11.10.2 Jubilant Biosys Business Overview
11.10.3 Jubilant Biosys Preclinical DMPK Studies Introduction
11.10.4 Jubilant Biosys Revenue in Preclinical DMPK Studies Business (2021–2026)
11.10.5 Jubilant Biosys Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Preclinical DMPK Studies Introduction
11.11.4 Creative Biolabs Revenue in Preclinical DMPK Studies Business (2021–2026)
11.11.5 Creative Biolabs Recent Development
11.12 Allucent
11.12.1 Allucent Company Details
11.12.2 Allucent Business Overview
11.12.3 Allucent Preclinical DMPK Studies Introduction
11.12.4 Allucent Revenue in Preclinical DMPK Studies Business (2021–2026)
11.12.5 Allucent Recent Development
11.13 Sai Life Sciences
11.13.1 Sai Life Sciences Company Details
11.13.2 Sai Life Sciences Business Overview
11.13.3 Sai Life Sciences Preclinical DMPK Studies Introduction
11.13.4 Sai Life Sciences Revenue in Preclinical DMPK Studies Business (2021–2026)
11.13.5 Sai Life Sciences Recent Development
11.14 Sygnature Discovery
11.14.1 Sygnature Discovery Company Details
11.14.2 Sygnature Discovery Business Overview
11.14.3 Sygnature Discovery Preclinical DMPK Studies Introduction
11.14.4 Sygnature Discovery Revenue in Preclinical DMPK Studies Business (2021–2026)
11.14.5 Sygnature Discovery Recent Development
11.15 Q2 Solutions
11.15.1 Q2 Solutions Company Details
11.15.2 Q2 Solutions Business Overview
11.15.3 Q2 Solutions Preclinical DMPK Studies Introduction
11.15.4 Q2 Solutions Revenue in Preclinical DMPK Studies Business (2021–2026)
11.15.5 Q2 Solutions Recent Development
11.16 Invitrocue
11.16.1 Invitrocue Company Details
11.16.2 Invitrocue Business Overview
11.16.3 Invitrocue Preclinical DMPK Studies Introduction
11.16.4 Invitrocue Revenue in Preclinical DMPK Studies Business (2021–2026)
11.16.5 Invitrocue Recent Development
11.17 Frontage
11.17.1 Frontage Company Details
11.17.2 Frontage Business Overview
11.17.3 Frontage Preclinical DMPK Studies Introduction
11.17.4 Frontage Revenue in Preclinical DMPK Studies Business (2021–2026)
11.17.5 Frontage Recent Development
11.18 BioDuro-Sundia
11.18.1 BioDuro-Sundia Company Details
11.18.2 BioDuro-Sundia Business Overview
11.18.3 BioDuro-Sundia Preclinical DMPK Studies Introduction
11.18.4 BioDuro-Sundia Revenue in Preclinical DMPK Studies Business (2021–2026)
11.18.5 BioDuro-Sundia Recent Development
11.19 Wuxi AppTec
11.19.1 Wuxi AppTec Company Details
11.19.2 Wuxi AppTec Business Overview
11.19.3 Wuxi AppTec Preclinical DMPK Studies Introduction
11.19.4 Wuxi AppTec Revenue in Preclinical DMPK Studies Business (2021–2026)
11.19.5 Wuxi AppTec Recent Development
11.20 Pharmaron
11.20.1 Pharmaron Company Details
11.20.2 Pharmaron Business Overview
11.20.3 Pharmaron Preclinical DMPK Studies Introduction
11.20.4 Pharmaron Revenue in Preclinical DMPK Studies Business (2021–2026)
11.20.5 Pharmaron Recent Development
11.21 JOINN Laboratories
11.21.1 JOINN Laboratories Company Details
11.21.2 JOINN Laboratories Business Overview
11.21.3 JOINN Laboratories Preclinical DMPK Studies Introduction
11.21.4 JOINN Laboratories Revenue in Preclinical DMPK Studies Business (2021–2026)
11.21.5 JOINN Laboratories Recent Development
11.22 Tigermed
11.22.1 Tigermed Company Details
11.22.2 Tigermed Business Overview
11.22.3 Tigermed Preclinical DMPK Studies Introduction
11.22.4 Tigermed Revenue in Preclinical DMPK Studies Business (2021–2026)
11.22.5 Tigermed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Charles River
LabCorp
Eurofins Scientific
PPD
Inotiv, Inc.
ChemPartner
Evotec AG
Medicilon
Crown Bioscience
Jubilant Biosys
Creative-Biolabs
Allucent
Sai Life Sciences
Sygnature Discovery
Q2 Solutions
Invitrocue
Frontage
Bioduro-Sundia
WuXi AppTec
Pharmaron
Joinn Laboratories
Tigermed
List of Tables
 Table 1. Global Preclinical DMPK Studies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of In Vitro
 Table 3. Key Players of In Vivo
 Table 4. Global Preclinical DMPK Studies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Preclinical DMPK Studies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Preclinical DMPK Studies Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Preclinical DMPK Studies Market Share by Region (2021–2026)
 Table 8. Global Preclinical DMPK Studies Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Preclinical DMPK Studies Market Share by Region (2027–2032)
 Table 10. Preclinical DMPK Studies Market Trends
 Table 11. Preclinical DMPK Studies Market Drivers
 Table 12. Preclinical DMPK Studies Market Challenges
 Table 13. Preclinical DMPK Studies Market Restraints
 Table 14. Global Preclinical DMPK Studies Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Preclinical DMPK Studies Market Share by Players (2021–2026)
 Table 16. Global Top Preclinical DMPK Studies Players by Tier (Tier 1, Tier 2, and Tier 3), based on Preclinical DMPK Studies Revenue, 2025
 Table 17. Ranking of Global Top Preclinical DMPK Studies Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Preclinical DMPK Studies Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Preclinical DMPK Studies, Headquarters and Area Served
 Table 20. Global Key Players of Preclinical DMPK Studies, Products and Applications
 Table 21. Global Key Players of Preclinical DMPK Studies, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Preclinical DMPK Studies Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Preclinical DMPK Studies Revenue Market Share by Type (2021–2026)
 Table 25. Global Preclinical DMPK Studies Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Preclinical DMPK Studies Revenue Market Share by Type (2027–2032)
 Table 27. Global Preclinical DMPK Studies Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Preclinical DMPK Studies Revenue Market Share by Application (2021–2026)
 Table 29. Global Preclinical DMPK Studies Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Preclinical DMPK Studies Revenue Market Share by Application (2027–2032)
 Table 31. North America Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Preclinical DMPK Studies Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Preclinical DMPK Studies Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Preclinical DMPK Studies Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
 Table 46. Charles River Company Details
 Table 47. Charles River Business Overview
 Table 48. Charles River Preclinical DMPK Studies Product
 Table 49. Charles River Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 50. Charles River Recent Development
 Table 51. Labcorp Company Details
 Table 52. Labcorp Business Overview
 Table 53. Labcorp Preclinical DMPK Studies Product
 Table 54. Labcorp Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 55. Labcorp Recent Development
 Table 56. Eurofins Scientific Company Details
 Table 57. Eurofins Scientific Business Overview
 Table 58. Eurofins Scientific Preclinical DMPK Studies Product
 Table 59. Eurofins Scientific Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 60. Eurofins Scientific Recent Development
 Table 61. PPD Company Details
 Table 62. PPD Business Overview
 Table 63. PPD Preclinical DMPK Studies Product
 Table 64. PPD Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 65. PPD Recent Development
 Table 66. Inotiv Company Details
 Table 67. Inotiv Business Overview
 Table 68. Inotiv Preclinical DMPK Studies Product
 Table 69. Inotiv Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 70. Inotiv Recent Development
 Table 71. ChemPartner Company Details
 Table 72. ChemPartner Business Overview
 Table 73. ChemPartner Preclinical DMPK Studies Product
 Table 74. ChemPartner Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 75. ChemPartner Recent Development
 Table 76. Evotec Company Details
 Table 77. Evotec Business Overview
 Table 78. Evotec Preclinical DMPK Studies Product
 Table 79. Evotec Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 80. Evotec Recent Development
 Table 81. Medicilon Company Details
 Table 82. Medicilon Business Overview
 Table 83. Medicilon Preclinical DMPK Studies Product
 Table 84. Medicilon Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 85. Medicilon Recent Development
 Table 86. Crown Bioscience Company Details
 Table 87. Crown Bioscience Business Overview
 Table 88. Crown Bioscience Preclinical DMPK Studies Product
 Table 89. Crown Bioscience Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 90. Crown Bioscience Recent Development
 Table 91. Jubilant Biosys Company Details
 Table 92. Jubilant Biosys Business Overview
 Table 93. Jubilant Biosys Preclinical DMPK Studies Product
 Table 94. Jubilant Biosys Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 95. Jubilant Biosys Recent Development
 Table 96. Creative Biolabs Company Details
 Table 97. Creative Biolabs Business Overview
 Table 98. Creative Biolabs Preclinical DMPK Studies Product
 Table 99. Creative Biolabs Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 100. Creative Biolabs Recent Development
 Table 101. Allucent Company Details
 Table 102. Allucent Business Overview
 Table 103. Allucent Preclinical DMPK Studies Product
 Table 104. Allucent Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 105. Allucent Recent Development
 Table 106. Sai Life Sciences Company Details
 Table 107. Sai Life Sciences Business Overview
 Table 108. Sai Life Sciences Preclinical DMPK Studies Product
 Table 109. Sai Life Sciences Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 110. Sai Life Sciences Recent Development
 Table 111. Sygnature Discovery Company Details
 Table 112. Sygnature Discovery Business Overview
 Table 113. Sygnature Discovery Preclinical DMPK Studies Product
 Table 114. Sygnature Discovery Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 115. Sygnature Discovery Recent Development
 Table 116. Q2 Solutions Company Details
 Table 117. Q2 Solutions Business Overview
 Table 118. Q2 Solutions Preclinical DMPK Studies Product
 Table 119. Q2 Solutions Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 120. Q2 Solutions Recent Development
 Table 121. Invitrocue Company Details
 Table 122. Invitrocue Business Overview
 Table 123. Invitrocue Preclinical DMPK Studies Product
 Table 124. Invitrocue Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 125. Invitrocue Recent Development
 Table 126. Frontage Company Details
 Table 127. Frontage Business Overview
 Table 128. Frontage Preclinical DMPK Studies Product
 Table 129. Frontage Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 130. Frontage Recent Development
 Table 131. BioDuro-Sundia Company Details
 Table 132. BioDuro-Sundia Business Overview
 Table 133. BioDuro-Sundia Preclinical DMPK Studies Product
 Table 134. BioDuro-Sundia Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 135. BioDuro-Sundia Recent Development
 Table 136. Wuxi AppTec Company Details
 Table 137. Wuxi AppTec Business Overview
 Table 138. Wuxi AppTec Preclinical DMPK Studies Product
 Table 139. Wuxi AppTec Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 140. Wuxi AppTec Recent Development
 Table 141. Pharmaron Company Details
 Table 142. Pharmaron Business Overview
 Table 143. Pharmaron Preclinical DMPK Studies Product
 Table 144. Pharmaron Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 145. Pharmaron Recent Development
 Table 146. JOINN Laboratories Company Details
 Table 147. JOINN Laboratories Business Overview
 Table 148. JOINN Laboratories Preclinical DMPK Studies Product
 Table 149. JOINN Laboratories Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 150. JOINN Laboratories Recent Development
 Table 151. Tigermed Company Details
 Table 152. Tigermed Business Overview
 Table 153. Tigermed Preclinical DMPK Studies Product
 Table 154. Tigermed Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
 Table 155. Tigermed Recent Development
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources
 Table 159. Authors List of This Report


List of Figures
 Figure 1. Preclinical DMPK Studies Picture
 Figure 2. Global Preclinical DMPK Studies Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Preclinical DMPK Studies Market Share by Type: 2025 vs 2032
 Figure 4. In Vitro Features
 Figure 5. In Vivo Features
 Figure 6. Global Preclinical DMPK Studies Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Preclinical DMPK Studies Market Share by Application: 2025 vs 2032
 Figure 8. Pharmaceutical Companies Case Studies
 Figure 9. Medical Device Companies Case Studies
 Figure 10. Others Case Studies
 Figure 11. Preclinical DMPK Studies Report Years Considered
 Figure 12. Global Preclinical DMPK Studies Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Preclinical DMPK Studies Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Preclinical DMPK Studies Market Share by Region: 2025 vs 2032
 Figure 15. Global Preclinical DMPK Studies Market Share by Players in 2025
 Figure 16. Global Preclinical DMPK Studies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Preclinical DMPK Studies Revenue in 2025
 Figure 18. North America Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Preclinical DMPK Studies Market Share by Country (2021–2032)
 Figure 20. United States Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Preclinical DMPK Studies Market Share by Country (2021–2032)
 Figure 24. Germany Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Preclinical DMPK Studies Market Share by Region (2021–2032)
 Figure 32. China Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Preclinical DMPK Studies Market Share by Country (2021–2032)
 Figure 40. Mexico Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Preclinical DMPK Studies Market Share by Country (2021–2032)
 Figure 44. Israel Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Charles River Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 48. Labcorp Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 49. Eurofins Scientific Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 50. PPD Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 51. Inotiv Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 52. ChemPartner Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 53. Evotec Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 54. Medicilon Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 55. Crown Bioscience Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 56. Jubilant Biosys Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 57. Creative Biolabs Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 58. Allucent Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 59. Sai Life Sciences Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 60. Sygnature Discovery Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 61. Q2 Solutions Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 62. Invitrocue Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 63. Frontage Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 64. BioDuro-Sundia Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 65. Wuxi AppTec Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 66. Pharmaron Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 67. JOINN Laboratories Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 68. Tigermed Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global ADME DMPK Studies Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Service Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Market Research Report 2024
Global DMPK Service Market Research Report 2024
Global PK PD Modeling Market Research Report 2024
In Vivo and In Vitro DMPK and ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacokinetic Service Market Research Report 2025
Global In Vivo Pharmacology Service Market Research Report 2024
Global Pharmacokinetics Testing Service Market Research Report 2024
Global Metabolism Detection Kit Market Research Report 2024
Global Radiolabelled ADME Studies Market Research Report 2024
In Vitro ADME Services Market
Global Metabolism Assay Kit Market Research Report 2024
Global In Vivo and In Vitro ADME Market Research Report 2024
In Vivo and In Vitro ADME and PK Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacokinetic Research Market Research Report 2024
In Vitro ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metabolomics Kit Market Research Report 2024
Global In Vivo Pharmacology Model Market Research Report 2024
Global In Vivo Pharmacology Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions